Groupe de htr-osteoanimalier

 The Asia-Pacific region, home to a significant portion of the world's glaucoma cases, is witnessing exciting advancements in the diagnosis and management of this sight-threatening condition. Driven by a growing geriatric population, increasing awareness, and rising healthcare expenditure, the glaucoma treatment market in the Asia-Pacific is projected for substantial growth.

Personalized Medicine and Novel Drug Delivery Take Center Stage:

The recent 7th Congress of the Asia-Pacific Glaucoma Society (APGC 2024) in Manila highlighted a strong emphasis on personalized treatment approaches. Experts underscored the importance of considering individual patient needs, including convenience, comfort, compliance, and cost, when selecting the most appropriate therapy. This includes a more nuanced approach to first-line medications, strategic switching or adding of drugs, and the growing consideration of preservative-free eye drops to minimize ocular surface disease.

Novel drug delivery systems are also gaining traction. Liposomal nanocarriers, capable of delivering both hydrophilic and hydrophobic drugs, are being explored…

Pearson learn provides an innovative way to engage with educational content. UNICCM highlights the platform’s features, including interactive assignments and real-time feedback. This makes learning more efficient and tailored to individual needs. Get expert insights on using pearson learn effectively from UNICCM.